Company record
Luminex Corporation
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about Luminex Corporation.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Nov 11 | Class II | Luminex Corporation Device |
LIAISON PLEX Gram-Negative Blood Culture Assay Catalog No. 20-005-303 Instructions for Use updated to include explicit guidance that repeat testing is recommended whenever a positive family-level only result is obtained. Issue may contribute to incorrect or delayed diagnosis of bloodstream infection. |